Eli Lilly (NYSE: LLY) trades at roughly $1,029 per share as of February 2026. The stock hit an all-time closing high of $1,108 in November 2025. Over the past five years, LLY has returned over 400% to shareholders.
Stock Price of Eli Lilly
Eli Lilly Stock Forecast
Wall Street analysts give Eli Lilly a consensus "Strong Buy" rating. Based on 42 analysts tracked by TickerNerd, the median 12-month price target is $1,145, with estimates ranging from $770 to $1,500. The bullish case rests on continued growth of Mounjaro and Zepbound, plus pipeline catalysts in Alzheimer's and oncology. The bear case centers on potential pricing pressure from GLP-1 competitors and manufacturing bottlenecks. Analysts project EPS could reach $46 by 2030, supporting a price target near $1,759 according to 24/7 Wall St. estimates.